[HTML][HTML] Minimal residual disease dynamics after venetoclax-obinutuzumab treatment: extended off-treatment follow-up from the randomized CLL14 study
O Al-Sawaf, C Zhang, T Lu, MZ Liao… - Journal of Clinical …, 2021 - ncbi.nlm.nih.gov
PURPOSE The CLL14 study has established one-year fixed-duration treatment of venetoclax
and obinutuzumab (Ven-Obi) for patients with previously untreated chronic lymphocytic …
and obinutuzumab (Ven-Obi) for patients with previously untreated chronic lymphocytic …
The PSMA-targeting half-life extended BiTE therapy AMG 160 has potent antitumor activity in preclinical models of metastatic castration-resistant prostate cancer
…, J Wahl, P Bogner, F Aeffner, M Friedrich, MZ Liao… - Clinical Cancer …, 2021 - AACR
Purpose: Metastatic castration-resistant prostate cancer (mCRPC) remains a disease with
high unmet medical need, as most patients do not achieve durable response with available …
high unmet medical need, as most patients do not achieve durable response with available …
Model‐Informed Therapeutic Dose Optimization Strategies for Antibody–Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration …
MZ Liao, D Lu, M Kågedal, D Miles… - Clinical …, 2021 - Wiley Online Library
Antibody–drug conjugates (ADCs) combine the specificity of an antibody with the cytotoxicity
of a chemical agent. They represent a rapidly evolving area of oncology drug development …
of a chemical agent. They represent a rapidly evolving area of oncology drug development …
Effects of pregnancy on the pharmacokinetics of metformin
MZ Liao, SKF Nichols, M Ahmed, S Clark… - Drug Metabolism and …, 2020 - ASPET
This study’s primary objective was to fully characterize the pharmacokinetics of metformin in
pregnant women with gestational diabetes mellitus (GDM) versus nonpregnant controls. …
pregnant women with gestational diabetes mellitus (GDM) versus nonpregnant controls. …
Clinical pharmacology considerations on recombinant adeno‐associated virus–based gene therapy
K Sun, MZ Liao - The Journal of Clinical Pharmacology, 2022 - Wiley Online Library
Recombinant adeno‐associated virus (AAV) is currently the most widely used platform for in
vivo gene therapy. Clinical pharmacology is a central field for AAV gene therapy, …
vivo gene therapy. Clinical pharmacology is a central field for AAV gene therapy, …
Simultaneous quantification of 25-hydroxyvitamin D3-3-sulfate and 25-hydroxyvitamin D3-3-glucuronide in human serum and plasma using liquid chromatography …
C Gao, MC Bergagnini-Kolev, MZ Liao, Z Wang… - … of Chromatography B, 2017 - Elsevier
25-hydroxyvitamin D 3 -3-sulfate (25-OHD 3 -S) and 25-hydroxyvitamin D 3 -3-glucuronide (25-OHD
3 -G) are major conjugative metabolites of vitamin D 3 found in the systemic …
3 -G) are major conjugative metabolites of vitamin D 3 found in the systemic …
P-gp/ABCB1 exerts differential impacts on brain and fetal exposure to norbuprenorphine
MZ Liao, C Gao, LM Shireman, B Phillips… - Pharmacological …, 2017 - Elsevier
… Multiple reaction monitoring transitions for each analyte and internal standard were m/z 414.2
> 83.1 for NBUP, m/z 590.3 > 414.2 for NBUP-G, and m/z 417.2 > 83.1for NBUP-d3. NBUP-…
> 83.1 for NBUP, m/z 590.3 > 414.2 for NBUP-G, and m/z 417.2 > 83.1for NBUP-d3. NBUP-…
Hepatic transport of 25-hydroxyvitamin D3 conjugates: a mechanism of 25-hydroxyvitamin D3 delivery to the intestinal tract
C Gao, MZ Liao, LW Han, KE Thummel… - Drug Metabolism and …, 2018 - ASPET
Vitamin D 3 is an important prohormone critical for maintaining calcium and phosphate
homeostasis in the body and regulating drug-metabolizing enzymes and transporters. 25-…
homeostasis in the body and regulating drug-metabolizing enzymes and transporters. 25-…
Buprenorphine, norbuprenorphine, R-methadone, and S-methadone upregulate BCRP/ABCG2 expression by activating aryl hydrocarbon receptor in human placental …
NK Neradugomma, MZ Liao, Q Mao - Molecular pharmacology, 2017 - ASPET
Opioid dependence during pregnancy is a rising concern. Maintaining addicted pregnant
women on long-acting opioid receptor agonist is the most common strategy to manage drug …
women on long-acting opioid receptor agonist is the most common strategy to manage drug …
Clinical pharmacology perspectives for adoptive cell therapies in oncology
Adoptive cell therapies (ACTs) have shown transformative efficacy in oncology with five US
Food and Drug Administration (FDA) approvals for chimeric antigen receptor (CAR) T‐cell …
Food and Drug Administration (FDA) approvals for chimeric antigen receptor (CAR) T‐cell …